Search

everythinglearnresearchcommunity

for

Search:↓

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Alopecia areata patients have a higher risk of other immune-related diseases.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Skin cells control immune cell placement, helping the skin respond better to challenges.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

A small 3D skin model helps study how immune cells move in the skin.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Loricrin affects skin immune function and homeostasis.

Transplanted hair follicles can change and adapt to new areas of the body, with the immune system possibly playing a role in this adjustment.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Machine learning can help find new ways to treat alopecia areata.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Researchers found four genes that could help diagnose severe alopecia areata early.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Higher BMI may increase the risk of psoriasis and some other skin diseases.

Stem cells help control the immune response to improve wound healing.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

TNF-alpha inhibitors can cause various immune-related skin issues.

A machine learning model can predict alopecia areata early using specific gene markers.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.